Baseline Characteristics of Adults with Classic Congenital Adrenal Hyperplasia Enrolled in CAHtalyst, a Phase 3 Study of Crinecerfont, a Corticotropin-Releasing Factor Type 1 Receptor Antagonist

Friday, May 10, 2024

11:00 AM – 11:15 AM CDT

Location: Collaboration Station, Empire Ballroom, Level 2

Poster Presenter(s)